LAS VEGAS & LOS ANGELES -- WaveScribe International Corp. (OTC:WSRB), today announced the introduction of its new physician-oriented dictation, transcription and documentation program, WaveScribeMD.
The WaveScribeMD program utilizes a breakthrough process designed for the dictating
WaveScribeMD is intended to yield many value-added benefits to the healthcare dictation and transcription market including HIPAA-supportive control, speed, accuracy, and possible cost savings. WaveScribe International Corp expects significant growth directly attributable from the WaveScribeMD program as its marketing program, now in progress, intensifies and expands into markets both nationwide and globally.
WaveScribe International Corporation is a leading national and international product and service solutions provider for the transcription industry. WaveScribe has several divisions to address industry-specific demands for such specialties as Healthcare, Med-Legal, Education and Entertainment.
For additional information about WaveScribe International Corporation: www.wavescribe.com
Special Note: Management believes certain statements in this press release may constitute ``forward-looking statements'' within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are made on the basis of management's views and assumptions regarding future events and business performance as of the time the statements are made. Actual results may differ materially from those expressed or implied. Such differences may result from actions taken by the company prior to its current fiscal year end, as well as from developments beyond the company's control, including changes in global economic conditions that may, among other things, affect the company's performance anticipated acquisitions or future business. In addition, changes in domestic competitive and economic conditions may also affect performance of all significant company businesses.